-
Product Insights
NewSerine/Threonine Protein Kinase Sgk1 – Drugs In Development, 2024
The Serine/Threonine Protein Kinase Sgk1 pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Sgk1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, and Immunology which include indications of Anaplastic Thyroid Cancer, Triple-Negative Breast Cancer (TNBC), Arrhythmias, Atrial Fibrillation, and Psoriasis. It also reviews key players involved in Serine/Threonine Protein Kinase...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tecarfarin Sodium in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tecarfarin Sodium in Thrombosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tecarfarin Sodium in Thrombosis Drug Details: Tecarfarin is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Etripamil in Supraventricular Tachycardia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etripamil in Supraventricular Tachycardia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Etripamil in Supraventricular Tachycardia Drug Details: Etripamil (MSP-2017) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abexinostat in Medullary Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abexinostat in Medullary Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abexinostat in Medullary Thyroid Cancer Drug Details: Abexinostat (PCI-24781) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abelacimab in Venous (Vein) Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abelacimab in Venous (Vein) Thrombosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abelacimab in Venous (Vein) Thrombosis Drug Details: Abelacimab is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tecarfarin Sodium in Thromboembolism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tecarfarin Sodium in Thromboembolism report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tecarfarin Sodium in Thromboembolism Drug Details: Tecarfarin is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Incobotulinumtoxin A in Peripheral Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Incobotulinumtoxin A in Peripheral Neuropathic Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Incobotulinumtoxin A in Peripheral Neuropathic Pain Drug Details: Incobotulinumtoxin...
-
Product Insights
NewBiofourmis Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biofourmis Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biofourmis Inc (Biofourmis) is a provider of advanced technology and clinical support for home care and digital therapies. The company offers Care@Home platform to deliver virtual care for patients with acute, post-acute, and chronic medical conditions; and software-based therapeutics to treat and manage patients with unmet clinical needs. Its DCT (decentralized clinical trials) solution provides telehealth, active ePRO and passive...
-
Product Insights
NewAcutus Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Acutus Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Acutus Medical Inc (Acutus Medical) is engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. It offers various products which include AcQMap system, AcQMap 3D imaging and mapping catheter; and AcQGuide steerable sheath. Acutus Medical’s electrofunctional mapping systems provides solutions to diagnose and treat atrial fibrillation. The company products enable physicians to visualize CT-quality scan, map...